CD8A and ovarian cancer: Taki et al. (12) demonstrated that ovarian cancer-derived CXCL1 and CXCL2 recruit immune-suppressive MDSCs from the bone marrow into the peritoneum, significantly inhibiting CD8+ T-cell proliferation.